MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    Models of Parkinson’s disease in vitro

    A. Dilzoda (Tashkent, Uzbekistan)

    Objective: The problem for experimental studies of the pathogenesis of Parkinson's disease is the impossibility of taking material from patients with this pathology, therefore, it…
  • 2018 International Congress

    Which is the best manual test to predict the daily living activities’ independence in people with Parkinson’s disease?

    C. Dionizio Dias, E. Okamoto, C. Miranda, M. d'Alencar, M.E. Piemonte (São Paulo, Brazil)

    Objective: The purpose of this study was to verify the power of Nine Hole Peg Test (9HPT) and manual strength (MS) to predict the decrease…
  • 2018 International Congress

    MRI volumetrics in parkinsonian syndromes

    K. Ma, A. Chan, L. Shi, J. Abrigo, T. Cheung, C. Lau, V. Mok (Hong Kong, Hong Kong)

    Objective: We aimed to explore the ability of MRI volumetrics by using an automated segmentation software called Accubrain in differentiating (1) between different parkinsonian syndromes…
  • 2018 International Congress

    Cerebrospinal fluid levels of cytokines in multiple system atrophy: A cross-sectional study of the atalan msa registry (CMSAR)

    Y. Compta, S. Dias, M. Pulido-Salgado, D. Giraldo, A. Pérez-Soriano, M. Fernández, A. Cámara, P. Bravo, E. Muñoz, J. Saura, MJ. Marti (Barcelona, Spain)

    Objective: To compare the cerebrospinal fluid (CSF) levels of 38 cytokines in multiple system atrophy (MSA) patients vs. control and Parkinson’s disease (PD) subjects. Background:…
  • 2018 International Congress

    How well can nurses recognize motor fluctuations in Parkinson’s disease: A survey of 238 registered nurses

    K. Boonpang, O. Jitkritsadakul, P. Plengsri, S. Chaiwong, N. Kantachadvanich, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To evaluate awareness of the three main parkinsonian motor symptomatologies, among general nursing population. Background: One aim of Parkinson’s disease (PD) management is to…
  • 2018 International Congress

    Quality of Life and Psychiatric Comorbidities Comparisons in Patients with Functional (Psychogenic) and Organic Movement Disorders

    T. Gendre, G. Carle, F. Mesrati, M. Houot, B. Degos, B. Garcin (Créteil, France)

    Objective: To compare the quality of life (QoL) and psychiatric comorbidities of patients with functional (psychogenic) movement disorders (FMD) and patients with organic movements disorders…
  • 2018 International Congress

    Sleep Abnormalities in patients with Parkinson’s disease having REM sleep behaviour disorder with and without Psychosis

    R. Yadav, V. Reddy, G. Kumar, L. George, A. Shashidharan, B. Kutty, P. Pal (Bangalore, India)

    Objective: To study the polysomnographic changes in patients of Parkinson’s disease with or without psychosis and evaluate any microarchitecture and microarchitecture changes. Background: Parkinson’s disease…
  • 2018 International Congress

    Objective monitoring of drug response in early PD patients using remote, at-home typing data through machine learning analysis

    M. Matarazzo, T. Arroyo-Gallego, P. Montero Escribano, V. Puertas-Martín, I. Butterworth, C. S. Mendoza, MJ. Ledesma-Carbayo, MJ. Catalán, JA. Molina-Arjona, F. Bermejo-Pareja, JC. Martínez Castrillo, L. López-Manzanares, A. Alonso-Cánovas, J. Herreros-Rodríguez, I. Obeso, P. Martínez Martín, JC. Martínez-Ávila, A. Gómez de-la-Cámara, M. Gray, JA. Obeso, L. Giancardo, Á. Sánchez-Ferro (Vancouver, BC, Canada)

    Objective: We designed an algorithm to detect response to medication in an early PD population using at-home, unsupervised, unobtrusive typing data. Background: Advances in technology…
  • 2018 International Congress

    Re-emergent Tremor in Parkinson’s Disease

    O. Dogu, M. Bozdag, N. Oksuz (Mersin, Turkey)

    Objective: The aim of the study was to evaluate the occurrence and the clinical characteristics of re-emergent tremor in a population of patients with PD.…
  • 2018 International Congress

    Characteristics in relation to demographic, disease related and clinical variables of a cohort of Parkinson’s disease patients from Northern Sri Lanka

    A. Keshavaraj, S. Kunathilagam (Jaffna, Sri Lanka)

    Objective: To evaluate motor and non-motor domains, as well as for demographic and disease related characteristics of patients with Parkinson’s disease and the relations with…
  • « Previous Page
  • 1
  • …
  • 217
  • 218
  • 219
  • 220
  • 221
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley